Cipla Ltd. — Capital/Financing Update 2021

Sep 18, 2021

18[th] September, 2021

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/ Madam,

Sub: Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015), we hereby notify that Cipla Limited has subscribed to 5% equity shares (on a fully diluted basis) of Swasth Digital Health Foundation, a not-for-profit organisation, with an aim to leverage digital technologies and build healthcare tech infrastructure.

The requisite details under SEBI Listing Regulations, 2015 read with Circular No. CIR/CFD/CMD/4/2015 dated 9[th] September, 2015 are enclosed as Annexure – I to this letter.

Kindly acknowledge receipt

Thanking you, Yours faithfully, For Cipla Limited

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2021.09.18 CHOPRA 20:37:25 +05'30'

Rajendra Chopra Company Secretary

Encl: Details as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

ANNEXURE – I

Details as per the SEBI circular no. CIR/CFD/CMD/4/2015 dated 9[th] September, 2015

Sr. No.	Particulars	Details
a.	Name of the target entity, details in brief such as size, turnover etc.	Name of the target entity: Swasth Digital Health Foundation (“Swasth”) Details of Target Entity: Swasth is a not-for-profit company incorporated under Section 8 of the Companies Act, 2013. It is an alliance of over 150 organisations engaged in leveraging digital technologies to improve healthcare outcomes and increase healthcare inclusion in India. The entity was incorporated on 3rdSeptember, 2020 and does not have any turnover.
b.	Whether the acquisition would fall within related party transaction(s) and whether the promoter/promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is one at "arms-length"	This transaction does not fall within the purview of related party transactions. None of the promoters / promoter group / group companies have any interest in Swasth.
c.	Industry to which the entity being acquired belongs	Healthcare Industry: Engaged in promoting and supporting telemedicine and healthcare.
d.	Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)	The investment is being made with an aim to leverage digital technologies and build healthcare tech infrastructure.
e.	Brief details of any governmental or regulatory approvals required for the acquisition	Not Applicable.
f.	Indicative time period for completion of the acquisition	The subscription to 5% equity stake in Swasth was completed on 18thSeptember, 2021

g.	Nature of consideration - whether cash consideration or share swap and details of the same	Cash Consideration.
h.	Cost of acquisition or the price at which the shares are acquired	Rs. 5,00,000/- towards subscription of 5000 equity shares, at a face value of Rs. 100/- each.
i.	Percentage of shareholding / control acquired and / or number of shares acquired	5% stake on a fully diluted basis (i.e. 5000 equity shares of Rs. 100/- each).
j.	Brief background about the entity acquired in terms of products / line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)	Swasth is engaged in leveraging digital technologies to improve healthcare outcomes including Health Claims Exchange, initiatives on Unified Health Interface (UHI) and Primary Care. It focuses proactively on serving the bottom of the pyramid. Born out of the first Covid wave in 2020, Swasth responded to the second Covid wave through multiple initiatives including deploying oxygenation equipment in 500+ districts, information resources and protocols under the Community Science Alliance. Date of Incorporation: 3rdSeptember, 2020 History of last 3 years turnover: Not applicable Country:India

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2021.09.18 CHOPRA 20:37:56 +05'30'